Robert F. Kennedy Jr., recently named Secretary of Health and Human Services, has announced sweeping plans to transform America’s approach to alternative medicine, including ending what he calls the FDA’s “war” on peptides, stem cells, and other non-pharmaceutical treatments.
He talked about it during an appearance on the Ultimate Human Podcast with host Gary Brecka. Kennedy outlined his vision for overhauling the nation’s largest government agency, which oversees a staggering $1.9 trillion budget, which is twice the size of the Pentagon.
His mission centers on addressing America’s chronic disease epidemic, which now consumes roughly 90% of the healthcare budget despite the U.S. spending more per capita on healthcare than any other nation.
“We’re going to end the war at FDA against alternative medicine: the war on stem cells, the war on chelating dr**s, the war on peptides,” Kennedy declared. He emphasized that this extends to vitamins, minerals, amino acids, and other nutrients that have faced regulatory obstacles despite their potential health benefits.
Kennedy’s personal experience illustrates the problem. He revealed that he had to travel to Antigua to receive stem cell treatment for his throat condition because such therapies aren’t readily available in the United States.
“They helped me enormously. Why did I have to go to Antigua for that?” he asked, highlighting the absurdity of Americans seeking basic treatments abroad.
The new HHS Secretary’s philosophy represents a fundamental shift in regulatory approach. Rather than the FDA dictating what physicians can prescribe and patients can access, Kennedy believes the agency should conduct rigorous science and inform the public of findings while respecting individual choice.
“We don’t want to have the wild west,” he explained, “but we also want to respect the intelligence of the American people.”
This stance challenges the current pharmaceutical-dominated healthcare model. Kennedy cited research from Peter Gøtzsche, a founder of the Cochrane Collaboration, showing that pharmaceutical d**gs are the third leading cause of death in America, after heart attacks and cancer.
Given these statistics, Kennedy questions why the government restricts access to alternative treatments while maintaining narrow pharmaceutical options that aren’t improving public health outcomes.
Kennedy’s mission involves purging conflicts of interest from health agencies that have been “captured” by the industries they’re supposed to regulate. He noted that seven of the eight most recent FDA commissioners immediately went to work for pharmaceutical companies after leaving their government positions, creating obvious incentives for regulatory favor.
The chronic disease epidemic Kennedy aims to address is staggering. When his uncle, President John F. Kennedy, was in office, the U.S. spent essentially nothing on chronic disease.
Today, that figure has exploded to approximately $1.6-1.7 trillion annually. Meanwhile, America leads the world in infant mortality, maternal mortality, obesity, type 2 diabetes, multiple chronic diseases, and had the highest COVID-19 death rate of any nation.
Kennedy’s approach involves redirecting 20% of the National Institutes of Health’s $46 billion budget toward replicating studies, publishing peer reviews transparently, and potentially ceasing publication in journals like The Lancet and The New England Journal of Medicine, which he claims have become “vessels for pharmaceutical propaganda.”
As Kennedy put it, “A healthy person has a thousand dreams. A sick person only has one.” With 60% of Americans suffering from chronic conditions, his mission to restore access to diverse treatment options represents more than policy change.
